Anna-Maria Andersson

Anna-Maria Andersson

Auto-generated profile, based on publicly available information

Anna-Maria Andersson

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Physiological Reviews
Verified
Journal Article
Open access
PDF file
NSNiels E. Skakkebaek
Niels E. Skakkebaek
EMEwa Rajpert-De Meyts
Ewa Rajpert-De Meyts
GLGermaine M. Buck Louis
Germaine M. Buck Louis
JTJorma Toppari
Jorma Toppari
AAAnna-Maria Andersson
Anna-Maria Andersson
AJAnders Juul
Anders Juul
It is predicted that Japan and European Union will soon experience appreciable decreases in their populations due to persistently low total fertility rates (TFR) below replacement level (2.1 child per woman). In the United States, where TFR has also declined, there are ethnic differences. Caucasians have rates below replacement, while TFRs among African-Americans and Hispanics are higher. We review possible links between TFR and trends in a range of male reproductive problems, including testicular cancer, disorders of sex development, cryptorchidism, hypospadias, low testosterone levels, poor semen quality, childlessness, changed sex ratio, and increasing demand for assisted reproductive techniques. We present evidence that several adult male reproductive problems arise in utero and are signs of testicular dysgenesis syndrome (TDS). Although TDS might result from genetic mutations, recent evidence suggests that it most often is related to environmental exposures of the fetal testis. However, environmental factors can also affect the adult endocrine system. Based on our review of genetic and environmental factors, we conclude that environmental exposures arising from modern lifestyle, rather than genetics, are the most important factors in the observed trends. These environmental factors might act either directly or via epigenetic mechanisms. In the latter case, the effects of exposures might have an impact for several generations post-exposure. In conclusion, there is an urgent need to prioritize research in reproductive physiology and pathophysiology, particularly in highly industrialized countries facing decreasing populations. We highlight a number of topics that need attention by researchers in human physiology, pathophysiology, environmental health sciences, and demography.

2 July 2007 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
HFHanne Frederiksen
Hanne Frederiksen
NSNiels E. Skakkebaek
Niels E. Skakkebaek
AAAnna‐Maria Andersson
Anna‐Maria Andersson

1 February 2006 in Environmental Health Perspectives
Verified
Journal Article
Open access
KMKatharina M. Main
Katharina M. Main
GMGerda K. Mortensen
Gerda K. Mortensen
MKMarko M. Kaleva
Marko M. Kaleva
KBKirsten A. Boisen
Kirsten A. Boisen
IDIda N. Damgaard
Ida N. Damgaard
NSNiels E. Skakkebæk
Niels E. Skakkebæk
Phthalates adversely affect the male reproductive system in animals. We investigated whether phthalate monoester contamination of human breast milk had any influence on the postnatal surge of reproductive hormones in newborn boys as a sign of testicular dysgenesis. Design: We obtained biologic samples from a prospective Danish–Finnish cohort study on cryptorchidism from 1997 to 2001. We analyzed individual breast milk samples collected as additive aliquots 1–3 months postnatally (n = 130; 62 cryptorchid/68 healthy boys) for phthalate monoesters [mono-methyl phthalate (mMP), mono-ethyl phthalate (mEP), mono-n-butyl phthalate (mBP), mono-benzyl phthalate (mBzP), mono-2-ethylhexyl phthalate (mEHP), mono-isononyl phthalate (miNP)]. We analyzed serum samples (obtained in 74% of all boys) for gonadotropins, sex-hormone binding globulin (SHBG), testosterone, and inhibin B. Results: All phthalate monoesters were found in breast milk with large variations [medians (minimum–maximum)]: mMP 0.10 (< 0.01–5.53 μg/L), mEP 0.95 (0.07–41.4 μg/L), mBP 9.6 (0.6–10,900 μg/L), mBzP 1.2 (0.2–26 μg/L), mEHP 11 (1.5–1,410 μg/L), miNP 95 (27–469 μg/L). Finnish breast milk had higher concentrations of mBP, mBzP, mEHP, and Danish breast milk had higher values for miNP (p = 0.0001–0.056). No association was found between phthalate monoester levels and cryptorchidism. However, mEP and mBP showed positive correlations with SHBG (r = 0.323, p = 0.002 and r = 0.272, p = 0.01, respectively); mMP, mEP, and mBP with LH:free testosterone ratio (r = 0.21–0.323, p = 0.002–0.044) and miNP with luteinizing hormone (r = 0.243, p = 0.019). mBP was negatively correlated with free testosterone (r = −0.22, p = 0.033). Other phthalate monoesters showed similar but nonsignificant tendencies. Conclusions: Our data on reproductive hormone profiles and phthalate exposures in newborn boys are in accordance with rodent data and suggest that human Leydig cell development and function may also be vulnerable to perinatal exposure to some phthalates. Our findings are also in line with other recent human data showing incomplete virilization in infant boys exposed to phthalates prenatally.

15 December 2021 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
NSNiels E. Skakkebæk
Niels E. Skakkebæk
RLRune Lindahl-Jacobsen
Rune Lindahl-Jacobsen
HLHagai Levine
Hagai Levine
AAAnna-Maria Andersson
Anna-Maria Andersson
NJNiels Jørgensen
Niels Jørgensen
AJAnders Juul
Anders Juul

1 November 2010 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
CHCasper P. Hagen
Casper P. Hagen
LALise Aksglaede
Lise Aksglaede
KSKaspar Sørensen
Kaspar Sørensen
KMKatharina M. Main
Katharina M. Main
MBMalene Boas
Malene Boas
AJAnders Juul
Anders Juul
Context: In adult women, anti-Müllerian hormone (AMH) is related to the ovarian follicle pool. Little is known about AMH in girls. Objective: The objective of the study was to provide a reference range for AMH in girls and adolescents and to evaluate AMH as a marker of ovarian function. Setting: The study was conducted at a tertiary referral center for pediatric endocrinology. Main Outcome Measures: We measured AMH in 926 healthy females (longitudinal values during infancy) as well as in 172 Turner syndrome (TS) patients according to age, karyotype (A: 45,X; B: miscellaneous karyotypes; C: 45,X/46,XX), and ovarian function (1: absent puberty; 2: cessation of ovarian function; 3: ongoing ovarian function). Results: AMH was undetectable in 54% (38 of 71) of cord blood samples (<2; <2–15 pmol/liter) (median; 2.5th to 97.5th percentile) and increased in all (37 of 37) infants from birth to 3 months (15; 4.5–29.5 pmol/liter). From 8 to 25 yr, AMH levels were stable (19.9; 4.7–60.1 pmol/liter), with the lower level of the reference range clearly above the detection limit. AMH levels were associated with TS-karyotype groups (median A vs. B: <2 vs. 3 pmol/liter, P = 0.044; B vs. C: 3 vs. 16 pmol/liter, P < 0.001) as well as with ovarian function (absent puberty vs. cessation of ovarian function: <2 vs. 6 pmol/liter, P = 0.004; cessation of ovarian function vs. ongoing ovarian function: 6 vs. 14 pmol/liter, P = 0.001). As a screening test of premature ovarian failure in TS, the sensitivity and specificity of AMH less than 8 pmol/liter was 96 and 86%, respectively. Conclusion: AMH seems to be a promising marker of ovarian function in healthy girls and TS patients.

1 July 2004 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
NJNadeem Rezaq Janjua
Nadeem Rezaq Janjua
BMBrian Mogensen
Brian Mogensen
AAAnna-Maria Andersson
Anna-Maria Andersson
JPJørgen Holm Petersen
Jørgen Holm Petersen
MHMette Henriksen
Mette Henriksen
HWHans Christian Wulf
Hans Christian Wulf